Rubicon reiterates IPO plans for ArborGen, laments languishing share price

Rubicon reiterates IPO plans for ArborGen, laments languishing share price
By Suze Metherell Dec. 5 (BusinessDesk) - Rubicon, the forestry biotech company spun out of Fletcher Challenge, reiterated plans for an initial public offer for ArborGen, the biotech forestry company it holds a third of, as it laments its languishing share price.  The Auckland-based company has been mulling an ArborGen share float since August 2013, after an aborted attempt in 2011, though it has to weigh up the realisation of immediate value against what it could get in the future, chairman Hugh Fletcher told shareholders at its annual m...